Child sacrifice: The FDA approved remdesivir based on a study in which 3 out of 53 children died The study was conducted by Gilead, the developer of remdesivir, and there was no control group. The mortality rate of children who are not treated for COVID is 0.005% (1 in 20,000 children dies). Based on this study, the mortality rate of children with remdesivir treatment is 5.66% (1 of 17.7 deaths). Dr. Meryl Nass: "Over 70% had an adverse reaction, 21% had a serious side effect, and three of the children died. Since there was no control group, it is unclear how Gilead or the FDA came to the conclusion that the drug benefits the children, because there is nothing to compare it with." ♟Subscribe and share the channel ♟ 👉🏼 Telegram: t.me/CheckMateNews